Anti-influenza Drugs Market Reports
1 Report
Anti-influenza Drugs Raw Material Suppliers, Raw Material Price Trend Analysis
Last Updated: 12/04/20241 Anti-influenza Drugs Key Raw Materials Analysis Currently, there are two main classes of anti-influenza drugs on the market: neuraminidase inhibitors (such as oseltamivir, zanamivir, and peramivir) and M2 ion channel blockers (such as amantadine, rimantadine). M2 ion channel blockers have only anti-influenza A virus activity, and amantadines are not recommended for the treatment of...